Time to ANC and Platelet Engraftment Evaluated by Previous Chemotherapy and Mobilization Regimen
| Chemotherapy . | Extensive Prior Chemotherapy . | Not Extensive Prior Chemotherapy . | ||
|---|---|---|---|---|
| . | Filgrastim Alone . | All Combinations . | Filgrastim Alone . | All Combinations . |
| . | (N = 5) . | (N = 18) . | (N = 5) . | (N = 7) . |
| ANC engraftment* to: | ||||
| 0.5 × 109/L (d) | ||||
| Median | 14.0 | 11.0 | 9.0 | 10.0 |
| Range | (9-14) | (8-17) | (9-10) | (8-10) |
| 1.0 × 109/L (d) | ||||
| Median | 14.0 | 11.0 | 10.0 | 10.0 |
| Range | (9-15) | (8-20) | (9-10) | (8-11) |
| Platelet engraftment† to: | ||||
| 20 × 109/L (d) | ||||
| Median | 23.0 | 12.5 | 12.0 | 10.0 |
| Range | (10-42) | (8-37) | (10-24) | (9-18) |
| 50 × 109/L (d) | ||||
| Median | 23.0 | 15.5 | 14.0 | 15.0 |
| Range | (12-193) | (10-66) | (12-33) | (12-18) |
| Chemotherapy . | Extensive Prior Chemotherapy . | Not Extensive Prior Chemotherapy . | ||
|---|---|---|---|---|
| . | Filgrastim Alone . | All Combinations . | Filgrastim Alone . | All Combinations . |
| . | (N = 5) . | (N = 18) . | (N = 5) . | (N = 7) . |
| ANC engraftment* to: | ||||
| 0.5 × 109/L (d) | ||||
| Median | 14.0 | 11.0 | 9.0 | 10.0 |
| Range | (9-14) | (8-17) | (9-10) | (8-10) |
| 1.0 × 109/L (d) | ||||
| Median | 14.0 | 11.0 | 10.0 | 10.0 |
| Range | (9-15) | (8-20) | (9-10) | (8-11) |
| Platelet engraftment† to: | ||||
| 20 × 109/L (d) | ||||
| Median | 23.0 | 12.5 | 12.0 | 10.0 |
| Range | (10-42) | (8-37) | (10-24) | (9-18) |
| 50 × 109/L (d) | ||||
| Median | 23.0 | 15.5 | 14.0 | 15.0 |
| Range | (12-193) | (10-66) | (12-33) | (12-18) |